loadpatents
name:-0.0097188949584961
name:-0.081308126449585
name:-0.0018179416656494
MARKLAND, JR.; Francis S. Patent Filings

MARKLAND, JR.; Francis S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MARKLAND, JR.; Francis S..The latest application filed is for "compositions and methods for treating ovarian cancer including preventing the recurrence thereof".

Company Profile
1.16.10
  • MARKLAND, JR.; Francis S. - Manhattan Beach CA US
  • Markland, Jr.; Francis S - Manhattan Beach CA
  • Markland, Jr.; Francis S. - Northridge CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods For Treating Ovarian Cancer Including Preventing The Recurrence Thereof
App 20160317610 - MARKLAND, JR.; Francis S. ;   et al.
2016-11-03
Biocompatible Implants and Methods of Making and Attaching the Same
App 20150105864 - Rowley; Adrian P. ;   et al.
2015-04-16
Biocompatible implants and methods of making and attaching the same
Grant 8,852,290 - Rowley , et al. October 7, 2
2014-10-07
Method of expressing proteins with disulfide bridges with enhanced yields and activity
Grant 8,802,394 - Minea , et al. August 12, 2
2014-08-12
Method of expressing proteins with disulfide bridges
Grant 8,685,668 - Minea , et al. April 1, 2
2014-04-01
Method Of Expressing Proteins With Disulfide Bridges
App 20130345399 - Minea; Radu O. ;   et al.
2013-12-26
Modified Adam Disintegrin Domain Polypeptides And Uses Thereof
App 20130045244 - Minea; Radu O. ;   et al.
2013-02-21
Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains
Grant 8,338,365 - Minea , et al. December 25, 2
2012-12-25
Inhibiting Integrin Receptor Binding With Non-native Monomeric Disintegrin Or Monomeric Disintegrin Domains
App 20120301453 - Minea; Radu O. ;   et al.
2012-11-29
Methods of expressing proteins with disulfide bridges
Grant 8,110,542 - Minea , et al. February 7, 2
2012-02-07
Combination Therapy for Treatment of Cancer
App 20110319345 - Markland, JR.; Francis S. ;   et al.
2011-12-29
Method Of Expressing Proteins With Disulfide Bridges With Enhanced Yields And Activity
App 20110300579 - Minea; Radu O. ;   et al.
2011-12-08
Combination therapy for treatment of cancer
Grant 8,008,256 - Markland, Jr. , et al. August 30, 2
2011-08-30
Methods of Expressing Proteins with Disulfide Bridges
App 20110097388 - MINEA; RADU O. ;   et al.
2011-04-28
Chimeric disintegrin domain
Grant 7,754,850 - Minea , et al. July 13, 2
2010-07-13
Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
Grant 7,718,615 - Markland, Jr. , et al. May 18, 2
2010-05-18
Contortrostatin CN and methods for its use in preventing metastasis and other conditions
Grant 7,220,724 - Markland, Jr. , et al. May 22, 2
2007-05-22
Contortrostain (CN) and methods for its use in preventing metastasis and other conditions
Grant 6,710,030 - Markland, Jr. , et al. March 23, 2
2004-03-23
Compositions containing a disintegrin and methods for its use in preventing metastasis and other conditions
Grant 5,814,609 - Markland, Jr. , et al. September 29, 1
1998-09-29
Compositions containing contortrostatin and methods for the use thereof
Grant 5,731,288 - Markland, Jr. , et al. March 24, 1
1998-03-24
Fibrinolytic enzymes
Grant 5,260,060 - Markland, Jr. , et al. November 9, 1
1993-11-09
Fibrinolytic enzyme from snake vernom
Grant 4,610,879 - Markland, Jr. , et al. September 9, 1
1986-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed